Look for:

ABLIVA AB


ISIN:
SE0002575340
WKN:
-

2023/09/29 17:14:58
Price
0.242 SEK
Difference 0.83% (0.00)

General attributes

ISINSE0002575340
SymbolABLI
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)22 EUR
BenchmarkOMX STOCKHOLM 30 INDEX

Market data

Bid (Bid size)0.2395 SEK (34,152)
Ask (Ask size)0.242 SEK (21,681)
Open0.24 SEK
High0.2495 SEK
Low0.237 SEK
Close (prev. day)0.24 SEK
VWAP0.242304 SEK
Volume (pcs)293,633
Trading volume71,148.62
Number of trades100
Last size5

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2023/09/29 en Global Equity Ratings PDF Download
2023/09/29 de Aktienempfehlungen Global PDF Download
2023/09/22 de Equity Weekly PDF Download
2023/09/18 de Aktienempfehlungen Österreich PDF Download
2023/09/18 de Equity Weekly PDF Download


2023/09/29 17:14:58
Price
0.242 SEK
Difference 0.83% (0.00)

General attributes

ISINSE0002575340
SymbolABLI
ExchangeNasdaq Stockholm
CurrencySEK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)22 EUR
BenchmarkOMX STOCKHOLM 30 INDEX

Market data

Bid (Bid size)0.2395 SEK (34,152)
Ask (Ask size)0.242 SEK (21,681)
Open0.24 SEK
High0.2495 SEK
Low0.237 SEK
Close (prev. day)0.24 SEK
VWAP0.242304 SEK
Volume (pcs)293,633
Trading volume71,148.62
Number of trades100
Last size5

Performance and Risk

6m1y3y
Perf (%)-3.20%+34.59%-73.89%
Perf (abs.)-0.01+0.06-0.68
Beta0.03-0.060.35
Volatility58.4178.5161.14
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)0.243 SEK (749,063)
Ø price 30 days | Ø volume 30 days (pcs.)0.241 SEK (2,767,336)
Ø price 100 days | Ø volume 100 days (pcs.)0.229 SEK (2,016,918)
Ø price 250 days | Ø volume 250 days (pcs.)0.228 SEK (5,207,559)
YTD High | date0.436 SEK (2023/01/17)
YTD Low | date0.165 SEK (2023/01/02)
52 Weeks High | date0.436 SEK (2023/01/17)
52 Weeks Low | date0.158 SEK (2022/10/28)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Stuttgart2023/09/2908:100.0247 EUR0.001
Nasdaq Stockholm2023/09/2917:140.242 SEK0.07100
London Stock Exchange2021/04/0616:070.7665 SEK0.001
Frankfurt2023/09/2912:300.0148 EUR0.002
FINRA other OTC Issues2023/04/0419:580.0000 USD0.001
Berlin2023/09/2921:430.0282 EUR0.0017

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=142984&ID_TYPE_IMAGE_LOGO=2

Contact Details

ABLIVA
- -
Biomedical Center, Sölvegatan 19 221 84 Lund
Telefon: + 46 (0)46 288 01 10
Fax: + 46 (0)46 888 83 48
E-mail: info@neurovive.se

Company Profile

-






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.